INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

BACKGROUND: The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β (Aβ) plaques and neurofibrillary tangles in the absence of symptomatic cognitive or functional decline. The duration of this preclinical stage in part depends on the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Moga, Daniela C., Beech, Brooke F., Abner, Erin L., Schmitt, Frederick A., El Khouli, Riham H., Martinez, Ashley I., Eckmann, Lynne, Huffmyer, Mark, George, Rosmy, Jicha, Gregory A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937673/
https://ncbi.nlm.nih.gov/pubmed/31888732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3993-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados